GB0906179D0 - Treatment of proteostatic desease - Google Patents
Treatment of proteostatic deseaseInfo
- Publication number
- GB0906179D0 GB0906179D0 GB0906179A GB0906179A GB0906179D0 GB 0906179 D0 GB0906179 D0 GB 0906179D0 GB 0906179 A GB0906179 A GB 0906179A GB 0906179 A GB0906179 A GB 0906179A GB 0906179 D0 GB0906179 D0 GB 0906179D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- proteostatic
- desease
- treatment
- proteostatic desease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0906179A GB0906179D0 (en) | 2009-04-09 | 2009-04-09 | Treatment of proteostatic desease |
US13/057,654 US20110237538A1 (en) | 2008-08-06 | 2009-08-04 | Treatment of lysosomal storage disorders and other proteostatic diseases |
PCT/GB2009/001918 WO2010015816A2 (en) | 2008-08-06 | 2009-08-04 | Treatment of lysosomal storage disorders and other proteostatic diseases |
EP09784866A EP2323652A2 (en) | 2008-08-06 | 2009-08-04 | Treatment of lysosomal storage disorders and other proteostatic diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0906179A GB0906179D0 (en) | 2009-04-09 | 2009-04-09 | Treatment of proteostatic desease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0906179D0 true GB0906179D0 (en) | 2009-05-20 |
Family
ID=40750378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0906179A Ceased GB0906179D0 (en) | 2008-08-06 | 2009-04-09 | Treatment of proteostatic desease |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0906179D0 (en) |
-
2009
- 2009-04-09 GB GB0906179A patent/GB0906179D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201304280B (en) | Treatment of jak2-mediated conditions | |
IL218575A0 (en) | Treatment of cancer | |
PL2652193T3 (en) | Treatment | |
HUE044426T2 (en) | Hbv treatment | |
GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
IL206491A0 (en) | Treatment of produce | |
GB0900599D0 (en) | Treatment | |
ZA201202213B (en) | Treatment of minerals | |
GB201018622D0 (en) | Treatment of liquids | |
GB201013898D0 (en) | Well treatment | |
GB201013573D0 (en) | Treatment | |
GB0908101D0 (en) | Treatment of stress | |
GB201001521D0 (en) | Treatment | |
PL2263454T3 (en) | Treatment composition | |
GB0913968D0 (en) | Treatment | |
GB0916686D0 (en) | Treatment of cancer | |
HK1178057A1 (en) | Treatment of osteoporosis | |
EP2440238A4 (en) | Methods of treatment | |
GB0906179D0 (en) | Treatment of proteostatic desease | |
GB201014097D0 (en) | Treatment | |
GB201001517D0 (en) | Treatment | |
GB0913427D0 (en) | Compounds for treatment of imflammation | |
GB0915434D0 (en) | Treatment of hepatitis C | |
GB0921757D0 (en) | Treatment of cancer | |
GB0908666D0 (en) | Treatment of proteostatic disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |